Table II.

Univariate and multivariate analysis of clinicopathological characteristics and overall survival in 59 patients with gastric cancer.

A, Univariate analysis
Clinical characteristics	Hazard ratio	95% confidence interval	P-value
Age (≥60 and <60)	1.101	0.751–2.451	0.931
Sex	0.461	0.251–1.072	0.442
Differentiation degree (high/middle/low)	0.908	0.742–2.411	0.658
Tumour, node and metastasis stage (I/II/III/IV)	5.455	1.890–11.080	0.055
Lymph node metastasis (no/yes)	0.723	0.818–3.524	0.620
STCAT16 expression level (high/low)	6.560	2.331–17.232	0.018
B, Multivariate analysis
Clinical characteristics	Hazard ratio	95% confidence interval	P-value
Age (≥60 and <60)	1.224	1.331–2.221	0.828
Sex	1.008	0.411–1.722	0.345
Differentiation degree (high/middle/low)	1.244	0.311–3.616	0.120
Tumour, node and metastasis stage (I/II/III/IV)	6.753	1.321–12.381	0.039
Lymph node metastasis (no/yes)	1.232	0.223–2.919	0.237
STCAT16 expression level (high/low)	7.393	1.928–15.156	0.025

STCAT16, stomach cancer-associated transcript 16.